Name
Session 1: Regulatory Updates from IMDRF Management Committee and Official Observers (Continued)
Date & Time
Tuesday, March 12, 2024, 11:00 AM - 11:50 AM
Laura Squire Mariela Aranda André Breisinger Irena Prat
Description

United Kingdom

  • Laura Squire, Chief Healthcare Quality and Access Officer, MHRA

11:00 to 11:10 AM

United States of America 

  • Melissa Torres, Associate Director for International Affairs, U.S. FDA

11:10 AM to 11:20 AM

Argentina (Official Observer)

  • Mariela Aranda, Head of the Service of In Vitro Diagnostic Products, ANMAT 

11:20 to 11:30 AM

Switzerland (Official Observer)

  • André Breisinger, Expert Medical Devices Regulation, Medical Devices Surveillance, Swissmedic

11:30 to 11:40 AM

World Health Organization (Official Observer)

  • Irena Prat, Team Lead, In Vitro Diagnostics Assessment, Prequalification Unit, WHO

11:40 to 11:50 AM

Location Name
Amphitheater
Full Address
Ronald Reagan Building & International Trade Center
1300 PENNSYLVANIA AVENUE NW
Washington, DC 20004
United States
Session Type
General Session